Hightidetx
1 known investors
Find your way into Hightidetx
Sign up to see every warm intro you have to Hightidetx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Hightidetx team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
HighTide Therapeutics is a biopharmaceutical company developing multifunctional therapies targeting cardiovascular-kidney-metabolic diseases. The company has a globally integrated pipeline with lead asset HTD1801 designated as a Fast Track and Orphan Drug candidate by the FDA.
Founders & leadership
LL
Liping LiuFounder, Chairwoman and CEO
Investors · 1
Frequently asked questions
- What does Hightidetx do?
- HighTide Therapeutics is a biopharmaceutical company developing multifunctional therapies targeting cardiovascular-kidney-metabolic diseases. The company has a globally integrated pipeline with lead asset HTD1801 designated as a Fast Track and Orphan Drug candidate by the FDA.
- Who founded Hightidetx?
- Hightidetx was founded by Liping Liu.
- Who are Hightidetx's investors?
- Hightidetx's investors include Blue Ocean Capital Group.